Questions discussed in this category
What about if the patient has mediastinal disease and ISRT is not an option?
Per the NCCN guideline for HR HD, if treated per OEPA-COPDAC, you can omit ISRT. This patient received treatment per AHOD1331, which recommends ISRT f...
DLCO 65% that is of unclear etiology but not due to disease and no cardiac or pulmonary functional limitations.
Given nationwide shortage in vinblastine, several of my patients under active therapy are facing delays in their therapies. Is it appropriate to subst...
Does the stage at diagnosis affect your decision?
Initial tumor size:18 cm. Partial response was achieved after cycle 2 and cycle 6 of chemotherapy. Complete response (Deauville 2, size: 6 cm) was ach...
If so, what treatment regimen would you recommend?
Do you use a cutoff of 10 cm? Do you measure the size of the largest node or measure the largest conglomerate or measure the total length of the entir...
What agents would have sufficient efficacy overlap to treat both?
Are there situations in which a Deauville 3 would cause you to escalate therapy?
How does your treatment approach vary depending on the underlying predisposition?
Do your recommendations differ between those who receive ABVD and escalated BEACOPP?
Do you recommend consultation with fertility specialists for all...
What would you recommend in the case of ABVD or BEACOPP?
Results of AHOD1331 are not yet known, but adults have started using Brentuximab upfront for high risk patients
Are there other regimens you employ for patients unsuitable for standard chemotherapy?
The current NCCN guideline version 2.2021 is a little confusing. On page HODG-2, the clinical staging/risk classification did not include ESR, b...
Have the RAPID or CALGB 5064 studies changed your treatment approach?
NCCN recommends either ISRT with rituximab/chemotherapy or ISRT alone in this scenario. What factors help your decision making?
There are conflicting reports of increased incidence of bleomycin-induced lung toxicity with G-CSF.
There are multiple regimens including IGEV and most recently reported results of BEGEV without preference on NCCN guidelines.
Would you still proceed to high-dose therapy and autologous SCT?
Would you incorporate radiation pre- or post- transplant? Or offer additional salvag...
Although not approved, for example, are you every using AVD-nivolumab?
Would the site of disease relapse play a role in your decision (i.e. isolated lymph node recurrence versus failure at primary site of disease)?
16673950821476207062842204871916219096124731338016452114081309812548122331143810625104109834956395839391932192908923703271586893659965546004586240404135
Papers discussed in this category
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-05-10
Int. J. Radiat. Oncol. Biol. Phys., 2012 Jun 05
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014-11-10
The Lancet. Oncology, 2018-02
Chest, 1997-03
J. Clin. Oncol.,
Clin Genitourin Cancer, 2017 Sep 04
Eur. Urol., 2020 Jan 01
Blood, 2019-05-16
Blood,
N. Engl. J. Med., 2015-04-23
J. Clin. Oncol., 2019 Sep 10
Blood, 2018 Sep 6
J Clin Oncol, 2017 Mar 14
Pediatric blood & cancer, 2017-04
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015-08-20
J Clin Oncol, 2020 Apr 28
Blood, 2009-09-03
N. Engl. J. Med., 2018-01-25
Lancet Haematol, 2020 Oct 01
J Clin Oncol, 2021 Apr 07
Blood, 2017-12-28
Clin Transl Oncol, 2020 Sep 17
J Assist Reprod Genet, 2020 Jun 02
Lancet Oncol, 2018 Sep 13
British journal of haematology, 2014-06
International journal of radiation oncology, biology, physics, 2019-06-01
Annals of oncology : official journal of the European Society for Medical Oncology, 2007-04
Blood, 2018-07-05
Blood,
Blood,
J Clin Oncol, 2021 Jun 25
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014-09-20
Blood, 2016-11-24
Lancet, 2012 Apr 04
Blood, 2018 Aug 30
The New England journal of medicine, 2016-06-23
Eur J Nucl Med Mol Imaging, 2016 May 07
J Clin Oncol, 2020 Sep 18
Clin Lymphoma Myeloma Leuk, 2020 Jul 29
Ann Oncol,
Journal of the National Comprehensive Cancer Network : JNCCN, 2012-05
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002-09-15
Cancer, 2010-09-15
Pediatric blood & cancer, 2006-03
Pediatric blood & cancer, 2014-04
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-03-20
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001-05-01
Annals of oncology : official journal of the European Society for Medical Oncology, 2011-02
Pediatric blood & cancer, 2015-01
The Lancet. Oncology, 2018-09
N Engl J Med, 2022 Nov 03
Lancet, 1993 Apr 24
Lancet, 2002 Jun 15
Crit Rev Oncol Hematol, 2014 May 02
Br J Haematol, 2014 Feb 07
Blood, 2023 Apr 27
J Clin Oncol, 2005 Sep 01
J Pediatr Hematol Oncol, 2004 Nov
Hemasphere, 2020 Jan 10
J Pediatr Hematol Oncol, 2001 Jan
Br J Cancer, 1992 Dec
Int J Radiat Oncol Biol Phys, 2001 Dec 01
J Clin Oncol, 2007 Apr 09
Pediatric blood & cancer, 2019-08
J Clin Oncol, 2022 Jul 22
The New England journal of medicine, 2022 Jul 13
The New England journal of medicine, 2024 Oct 17